Properties and benefits investigated
PepT1-mediated cellular uptake; reduced NF-κB/MAPK activation and inflammatory cytokine release in cell models; reduced inflammation in experimental mouse colitis.
AVITUS RESEARCHKPV
Recovery
KPV
Alpha-MSH C-terminal tripeptide studied in inflammatory-signaling models.
- Research category
- Recovery
- Intended context
- Laboratory research only
For research use only. Not for human or veterinary use. No claims of safety, efficacy or therapeutic benefit.
Evidence and limitations
The cited findings are preclinical (cells or animals), not demonstrated therapeutic benefits in people.
References
PMID: 18061177
Product specifications.
Contact the Avitus team to confirm available presentations, product specifications and pricing for your research requirements.